A citation-based method for searching scientific literature

Xuesen Zhao, Danying Chen, Xinglin Li, Lauren Griffith, Jinhong Chang, Ping An, Ju-Tao Guo. J Mol Biol 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model.
Hua-Hao Fan, Li-Qin Wang, Wen-Li Liu, Xiao-Ping An, Zhen-Dong Liu, Xiao-Qi He, Li-Hua Song, Yi-Gang Tong. Chin Med J (Engl) 2020
139
100

Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms.
Bodee Nutho, Panupong Mahalapbutr, Kowit Hengphasatporn, Nawanwat Chainuwong Pattaranggoon, Nattapon Simanon, Yasuteru Shigeta, Supot Hannongbua, Thanyada Rungrotmongkol. Biochemistry 2020
117
100

GalaxyRefine: Protein structure refinement driven by side-chain repacking.
Lim Heo, Hahnbeom Park, Chaok Seok. Nucleic Acids Res 2013
356
100

Can Papain-like Protease Inhibitors Halt SARS-CoV-2 Replication?
Biplab K Maiti. ACS Pharmacol Transl Sci 2020
20
100

Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
Qinhai Ma, Runfeng Li, Weiqi Pan, Wenbo Huang, Bin Liu, Yuqi Xie, Zhoulang Wang, Chufang Li, Haiming Jiang, Jicheng Huang,[...]. Phytomedicine 2020
37
100

The molecular biology of coronaviruses.
Paul S Masters. Adv Virus Res 2006
868
100

g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations.
Rashmi Kumari, Rajendra Kumar, Andrew Lynn. J Chem Inf Model 2014
100

Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity.
Brian H Harcourt, Dalia Jukneliene, Amornrat Kanjanahaluethai, John Bechill, Kari M Severson, Catherine M Smith, Paul A Rota, Susan C Baker. J Virol 2004
296
100

Antiviral effect of mefloquine on feline calicivirus in vitro.
Phillip McDonagh, Paul A Sheehy, Anne Fawcett, Jacqueline M Norris. Vet Microbiol 2015
13
100

Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating activity of SARS-CoV papain-like protease.
Kiira Ratia, Andrew Kilianski, Yahira M Baez-Santos, Susan C Baker, Andrew Mesecar. PLoS Pathog 2014
130
100

Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.
Donghyuk Shin, Rukmini Mukherjee, Diana Grewe, Denisa Bojkova, Kheewoong Baek, Anshu Bhattacharya, Laura Schulz, Marek Widera, Ahmad Reza Mehdipour, Georg Tascher,[...]. Nature 2020
394
100

The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery.
Ziyang Fu, Bin Huang, Jinle Tang, Shuyan Liu, Ming Liu, Yuxin Ye, Zhihong Liu, Yuxian Xiong, Wenning Zhu, Dan Cao,[...]. Nat Commun 2021
67
100

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.
Kanchan Anand, John Ziebuhr, Parvesh Wadhwani, Jeroen R Mesters, Rolf Hilgenfeld. Science 2003
100


Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
Roujian Lu, Xiang Zhao, Juan Li, Peihua Niu, Bo Yang, Honglong Wu, Wenling Wang, Hao Song, Baoying Huang, Na Zhu,[...]. Lancet 2020
100

Lack of antiviral activity of darunavir against SARS-CoV-2.
Sandra De Meyer, Denisa Bojkova, Jindrich Cinatl, Ellen Van Damme, Christophe Buyck, Marnix Van Loock, Brian Woodfall, Sandra Ciesek. Int J Infect Dis 2020
83
100

The biology of coronaviruses.
S Siddell, H Wege, V Ter Meulen. J Gen Virol 1983
256
100


MolProbity: More and better reference data for improved all-atom structure validation.
Christopher J Williams, Jeffrey J Headd, Nigel W Moriarty, Michael G Prisant, Lizbeth L Videau, Lindsay N Deis, Vishal Verma, Daniel A Keedy, Bradley J Hintze, Vincent B Chen,[...]. Protein Sci 2018
100

Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design.
Wioletta Rut, Zongyang Lv, Mikolaj Zmudzinski, Stephanie Patchett, Digant Nayak, Scott J Snipas, Farid El Oualid, Tony T Huang, Miklos Bekes, Marcin Drag,[...]. Sci Adv 2020
175
100

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu,[...]. Lancet 2020
100

Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease.
Brendan T Freitas, Ian A Durie, Jackelyn Murray, Jaron E Longo, Holden C Miller, David Crich, Robert Jeff Hogan, Ralph A Tripp, Scott D Pegan. ACS Infect Dis 2020
130
100

Multi-targeting of functional cysteines in multiple conserved SARS-CoV-2 domains by clinically safe Zn-ejectors.
Karen Sargsyan, Chien-Chu Lin, Ting Chen, Cédric Grauffel, Yi-Ping Chen, Wei-Zen Yang, Hanna S Yuan, Carmay Lim. Chem Sci 2020
37
100

High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors.
Yao Zhao, Xiaoyu Du, Yinkai Duan, Xiaoyan Pan, Yifang Sun, Tian You, Lin Han, Zhenming Jin, Weijuan Shang, Jing Yu,[...]. Protein Cell 2021
32
100

Structure of the multiple functional domains from coronavirus nonstructural protein 3.
Mengxia Li, Gang Ye, Yu Si, Zhou Shen, Zhu Liu, Yuejun Shi, Shaobo Xiao, Zhen F Fu, Guiqing Peng. Emerg Microbes Infect 2021
5
100

Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo.
Stuart Weston, Christopher M Coleman, Robert Haupt, James Logue, Krystal Matthews, Yize Li, Hanako M Reyes, Susan R Weiss, Matthew B Frieman. J Virol 2020
119
100

Identification of a new human coronavirus.
Lia van der Hoek, Krzysztof Pyrc, Maarten F Jebbink, Wilma Vermeulen-Oost, Ron J M Berkhout, Katja C Wolthers, Pauline M E Wertheim-van Dillen, Jos Kaandorp, Joke Spaargaren, Ben Berkhout. Nat Med 2004
100

An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19.
Dafydd R Owen, Charlotte M N Allerton, Annaliesa S Anderson, Lisa Aschenbrenner, Melissa Avery, Simon Berritt, Britton Boras, Rhonda D Cardin, Anthony Carlo, Karen J Coffman,[...]. Science 2021
224
100

Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia.
Patrick C Y Woo, Susanna K P Lau, Chung-ming Chu, Kwok-hung Chan, Hoi-wah Tsoi, Yi Huang, Beatrice H L Wong, Rosana W S Poon, James J Cai, Wei-kwang Luk,[...]. J Virol 2005
917
100

A Trial of Lopinavir-Ritonavir in Covid-19. Reply.
Bin Cao, Dingyu Zhang, Chen Wang. N Engl J Med 2020
51
100



LY6E impairs coronavirus fusion and confers immune control of viral disease.
Stephanie Pfaender, Katrina B Mar, Eleftherios Michailidis, Annika Kratzel, Ian N Boys, Philip V'kovski, Wenchun Fan, Jenna N Kelly, Dagny Hirt, Nadine Ebert,[...]. Nat Microbiol 2020
99
100

Repurposing Known Drugs as Covalent and Non-covalent Inhibitors of the SARS-CoV-2 Papain-Like Protease.
Pietro Delre, Fabiana Caporuscio, Michele Saviano, Giuseppe Felice Mangiatordi. Front Chem 2020
22
100

Coronavirus pathogenesis.
Susan R Weiss, Julian L Leibowitz. Adv Virus Res 2011
408
100

MMPBSA.py: An Efficient Program for End-State Free Energy Calculations.
Bill R Miller, T Dwight McGee, Jason M Swails, Nadine Homeyer, Holger Gohlke, Adrian E Roitberg. J Chem Theory Comput 2012
100

Keio multicenter trial in high-dose interferon-alpha 2b treatment for chronic hepatitis C. Keio Interferon-alpha 2b Study Group.
H Saito, K Tsuchimoto, S Miyaguchi, S Tada, K Sawaguchi, K Komatsu, K Kaneko, T Watanabe, T Morizane, H Ishii. Keio J Med 1996
5
100

Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model.
Jean-Sélim Driouich, Maxime Cochin, Guillaume Lingas, Grégory Moureau, Franck Touret, Paul-Rémi Petit, Géraldine Piorkowski, Karine Barthélémy, Caroline Laprie, Bruno Coutard,[...]. Nat Commun 2021
54
100

Polyribonucleotide-anthraquinone interactions: in vitro antiviral activity studies.
J M Jamison, K Krabill, D G Flowers, C C Tsai. Cell Biol Int Rep 1990
4
100

Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation.
Mathieu Gendrot, Julien Andreani, Manon Boxberger, Priscilla Jardot, Isabelle Fonta, Marion Le Bideau, Isabelle Duflot, Joel Mosnier, Clara Rolland, Hervé Bogreau,[...]. Travel Med Infect Dis 2020
39
100

Identification of a flavonoid isolated from plum (Prunus domestica) as a potent inhibitor of Hepatitis C virus entry.
Mihika Bose, Mohini Kamra, Ranajoy Mullick, Santanu Bhattacharya, Saumitra Das, Anjali A Karande. Sci Rep 2017
12
100

A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication.
Kiira Ratia, Scott Pegan, Jun Takayama, Katrina Sleeman, Melissa Coughlin, Surendranath Baliji, Rima Chaudhuri, Wentao Fu, Bellur S Prabhakar, Michael E Johnson,[...]. Proc Natl Acad Sci U S A 2008
274
100

Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis.
Toshie Manabe, Dan Kambayashi, Hiroyasu Akatsu, Koichiro Kudo. BMC Infect Dis 2021
38
100

Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.
Richard A Friesner, Jay L Banks, Robert B Murphy, Thomas A Halgren, Jasna J Klicic, Daniel T Mainz, Matthew P Repasky, Eric H Knoll, Mee Shelley, Jason K Perry,[...]. J Med Chem 2004
100

PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.
Alexander W Schüttelkopf, Daan M F van Aalten. Acta Crystallogr D Biol Crystallogr 2004
100

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
Manli Wang, Ruiyuan Cao, Leike Zhang, Xinglou Yang, Jia Liu, Mingyue Xu, Zhengli Shi, Zhihong Hu, Wu Zhong, Gengfu Xiao. Cell Res 2020
100

Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro.
Sébastien Pasquereau, Zeina Nehme, Sandy Haidar Ahmad, Fadoua Daouad, Jeanne Van Assche, Clémentine Wallet, Christian Schwartz, Olivier Rohr, Stéphanie Morot-Bizot, Georges Herbein. Viruses 2021
29
100

Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus.
Santhana G Devaraj, Nan Wang, Zhongbin Chen, Zihong Chen, Monica Tseng, Naina Barretto, Rongtuan Lin, Clarence J Peters, Chien-Te K Tseng, Susan C Baker,[...]. J Biol Chem 2007
283
100

Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme.
Kiira Ratia, Kumar Singh Saikatendu, Bernard D Santarsiero, Naina Barretto, Susan C Baker, Raymond C Stevens, Andrew D Mesecar. Proc Natl Acad Sci U S A 2006
270
100

Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2.
Theresa Klemm, Gregor Ebert, Dale J Calleja, Cody C Allison, Lachlan W Richardson, Jonathan P Bernardini, Bernadine Gc Lu, Nathan W Kuchel, Christoph Grohmann, Yuri Shibata,[...]. EMBO J 2020
159
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.